Federated Hermes Inc. Sells 4,750 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Federated Hermes Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 146,118 shares of the healthcare conglomerate’s stock after selling 4,750 shares during the quarter. Federated Hermes Inc.’s holdings in UnitedHealth Group were worth $76,927,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in UNH. Kraft Davis & Associates LLC grew its position in shares of UnitedHealth Group by 3.4% during the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after purchasing an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after acquiring an additional 19 shares in the last quarter. Secure Asset Management LLC increased its holdings in shares of UnitedHealth Group by 0.8% in the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after buying an additional 19 shares during the last quarter. Bensler LLC grew its position in UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after acquiring an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX grew its holdings in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Performance

Shares of UNH opened at $493.16 on Friday. The firm has a market capitalization of $454.66 billion, a P/E ratio of 30.14, a PEG ratio of 1.31 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The business has a fifty day moving average of $488.97 and a 200 day moving average of $515.22. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the business posted $6.26 earnings per share. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.